Tilray Shares Spike To Session High On Volume As Traders Circulate CBD Guidance Draft Doc From FDA Related To 100 mg/mL Solution Of Cannabidiol For In Vivo Bioequivalence Study; BZ NOTE: Tilray Not Specifically Mentioned In Draft Doc

https://www.scribd.com/document/477185299/FDA-CBD-guidance?secret_password=jJZsXslTAa1GrW1DDh7g


Image
igniteit
September 23, 2020
Share: